SCHEMBL20022698

SCHEMBL20022698

O=C(Nc1ccc(Cc2ccccc2)cc1)c1ccccc1S

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.58
▸ CA1 P00915 1/20 0.58
▸ CA2 P00918 1/20 0.58
▸ CA5A P35218 1/20 0.58
▸ CA9 Q16790 1/20 0.58
▸ CA5B Q9Y2D0 1/20 0.58
▸ ALDH1A1 P00352 3/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ ADRB2 P07550 1/20 0.51
▸ SLC1A3 P43003 1/20 0.51
▸ SLC1A2 P43004 1/20 0.51
▸ SLC1A1 P43005 1/20 0.51
▸ FFAR1 O14842 1/20 0.51
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ MAPT P10636 2/20 0.51
▸ SMO Q99835 2/20 0.50
▸ BCL2 P10415 1/20 0.50
▸ KDM4E B2RXH2 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ GAA P10253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1897443 0.85 CA12 (0.66) CA12CA1CA2CA5ACA9
SCHEMBL16426269 0.84 ALDH1A1 (0.71) ALDH1A1KMT2AADRB2FFAR1SMN1; SMN2
SCHEMBL1496373 0.79 CA12 (0.63) CA12CA1CA2CA5ACA9
SCHEMBL20022688 0.78 PNLIP (0.70) CA12CA1CA2CA5ACA9
SCHEMBL675754 0.77 ALDH1A1 (0.65) ALDH1A1KMT2AFFAR1SMN1; SMN2MAPT
SCHEMBL5154816 0.76 PTPN1 (0.69) ALDH1A1KMT2AFFAR1SMN1; SMN2MAPT
SCHEMBL23409198 0.76 ALDH1A1 (0.63) ALDH1A1KMT2AFFAR1SMN1; SMN2MAPT
SCHEMBL1695994 0.76 ALDH1A1 (0.63) ALDH1A1KMT2AFFAR1SMN1; SMN2MAPT
SCHEMBL25918279 0.76 ALDH1A1 (0.65) ALDH1A1KMT2AFFAR1SMN1; SMN2MAPT
SCHEMBL3773254 0.76 SLC1A3 (0.58) CA12CA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180092908-A1 SMALL MOLECULE OXIDIZERS OF PDI AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2018-04-05 — — US disclosed
US-20180092908-A1 SMALL MOLECULE OXIDIZERS OF PDI AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2018-04-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180092908-A1 SMALL MOLECULE OXIDIZERS OF PDI AND THEIR USE PDIA5, PDIA4, PDIA6 CA12 1291/4885CA1 326/4885CA2 1249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback